Loading...
MSCatalog No. MS991
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Cleaved PARP Human ELISA Kit
| Sample | n | Mean | SD | CV% |
|---|---|---|---|---|
| 1 | 8 | 4.9% |
| Sample | n | Mean | SD | CV% |
|---|---|---|---|---|
| 1 | 4 | 10.9% |
1 x 96 well plate
Cell culture extracts, Tissue Extracts
Sandwich
15 µg/ml
8 µg/ml - 250 µg/ml
95%
| Sample type | Average % | Range % |
|---|---|---|
| Cell culture supernatant | 93 | 82 - 109 |
| Serum | 106 | 100 - 110 |
Reacts with
Human
Sandwich ELISAmore details
Please see Notes section
| Components | Identifier | 1 x 96 tests |
|---|---|---|
| 10X Blocking Buffer | P/N 8209802 | 1 x 6ml |
| ab75607 - 10X Detector Antibody | P/N 8209536 | 1 x 700µl |
| 10X HRP Label | P/N 8206026 | 1 x 1ml |
| 20X Buffer | P/N 8209534 | 1 x 20ml |
| 2X Extraction Buffer | P/N 8209533 | 1 x 15ml |
| PARP Microplate | P/N 8209535 | 1 unit |
| TMB Development Solution | P/N 8206045 | 1 x 6ml |
Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> DNA Damage Response >> DNA Damage Recognition
Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> Base Excision Repair
Epigenetics and Nuclear Signaling >> Chromatin Modifying Enzymes >> ADP-ribosylation
Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. Mediates the poly(ADP-ribosyl)ation of APLF and CHFR. Positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150.
Contains 1 BRCT domain.
Contains 1 PARP alpha-helical domain.
Contains 1 PARP catalytic domain.
Contains 2 PARP-type zinc fingers.
Phosphorylated by PRKDC. Phosphorylated upon DNA damage, probably by ATM or ATR.
Poly-ADP-ribosylated by PARP2. Poly-ADP-ribosylation mediates the recruitment of CHD1L to DNA damage sites.
S-nitrosylated, leading to inhibit transcription regulation activity.
Nucleus.
Target information above from: UniProt accessionP09874
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Our Abpromise guarantee covers the use of ab119690 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
sELISA
ELISA - Cleaved PARP Human ELISA Kit (ab119690)

Figure 1. Example standard curve. A dilution series of pellet extracts in Incubation Buffer in the working range of the assay. The lysates were prepared from a pellet of HeLa cells treated with Staurosporine.
ELISA - Cleaved PARP Human ELISA Kit (ab119690)

Figure 2. Example experimental analysis of pellet extracts prepared from HeLa (A) or Jurkat (B) cells treated with vehicle or Staurosporine. Cell extracts at varying concentrations within the working range of the assay were analyzed. Absolute signals (without zero standard subtraction) are shown. Dashed lines represent signals of zero standard (Incubation Buffer only).
ELISA - Cleaved PARP Human ELISA Kit (ab119690)

Figure 3. Example of IC50 determination. Lysates were prepared by direct in-well lysis without media removal from Jurkat and HeLa cells grown and treated with variable doses of Staurosporine in a 96-well plate. Absolute signals of Jurkat lysates (corresponding to 10X105 cells/mL) and HeLa lysates (corresponding to 2.5x105 cells/mL) are shown, respectively, in A and B.
ELISA - Cleaved PARP Human ELISA Kit (ab119690)

Figure 4. Demonstration of assay specificity by inducing PARP cleavage with Staurosporine. (A) Cleaved PARP ELISA using vehicle or Staurosporine treated HeLa extracts (250 ug/mL) or Jurkat extracts (125 ug/mL). (B) Western blot using the Cleaved PARP ELISA capture antibody (ab110315). (C) Western blot using the Cleaved PARP ELISA detector antibody (ab75607). The same extract preparations of vehicle-treated (lane1) or Staurosporine-treated (lane 2) HeLa cells, and of vehicle-treated (lane 3) or Staurosporine-treated (lane 4) Jurkat cells were used in both ELISA and Western blot analyses. The data demonstrate that the ELISA kit measures specifically the 89 kDa fragment of PARP-1. Note of complete cleavage of PARP in the Staurosporine-treated HeLa and Jurkat samples (in C).
ab119690 has not yet been referenced specifically in any publications.
Publishing research using ab119690? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

Figure 1. Example standard curve. A dilution series of pellet extracts in Incubation Buffer in the working range of the assay. The lysates were prepared from a pellet of HeLa cells treated with Staurosporine.

Figure 2. Example experimental analysis of pellet extracts prepared from HeLa (A) or Jurkat (B) cells treated with vehicle or Staurosporine. Cell extracts at varying concentrations within the working range of the assay were analyzed. Absolute signals (without zero standard subtraction) are shown. Dashed lines represent signals of zero standard (Incubation Buffer only).

Figure 3. Example of IC50 determination. Lysates were prepared by direct in-well lysis without media removal from Jurkat and HeLa cells grown and treated with variable doses of Staurosporine in a 96-well plate. Absolute signals of Jurkat lysates (corresponding to 10X105 cells/mL) and HeLa lysates (corresponding to 2.5x105 cells/mL) are shown, respectively, in A and B.

Figure 4. Demonstration of assay specificity by inducing PARP cleavage with Staurosporine. (A) Cleaved PARP ELISA using vehicle or Staurosporine treated HeLa extracts (250 ug/mL) or Jurkat extracts (125 ug/mL). (B) Western blot using the Cleaved PARP ELISA capture antibody (ab110315). (C) Western blot using the Cleaved PARP ELISA detector antibody (ab75607). The same extract preparations of vehicle-treated (lane1) or Staurosporine-treated (lane 2) HeLa cells, and of vehicle-treated (lane 3) or Staurosporine-treated (lane 4) Jurkat cells were used in both ELISA and Western blot analyses. The data demonstrate that the ELISA kit measures specifically the 89 kDa fragment of PARP-1. Note of complete cleavage of PARP in the Staurosporine-treated HeLa and Jurkat samples (in C).
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
